Role of epidermal growth factor receptor in the metastasis of intraocular melanomas

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 7, 1998, Pages 1067-1075

  Ma, Ding ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL SURVIVAL; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; LIVER NEOPLASMS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM CIRCULATING CELLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UVEAL NEOPLASMS;

EID: 0031806675     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert D. Epidemiologic aspects of uveal melanoma. Surv Ophtghalmol. 1988;32: 239-251.
2. Gamel JW, Mclean IW, McCurdy JB. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer. 1993;71:2299-2305.
3. Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol. 1985;103:796-798.
4. Albert DM, Niffenegger AS, Willson JKV. Treatment of metastatic uveal melanoma: review and recommendations. Sum Ophthalmol. 1992;36:429.
5. Fidler IJ. Special lecture: critical factors in the biology of human cancer metastasis. Twenty eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 1990;50:6130-6138.
6. Fidler IJ, Radinsky R. Editorial. Genetic control of cancer metastasis. J Natl Cancer Inst. 1990;82:166-168.
7. Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol. 1973;242:148-149.
8. Niederkorn JY, Mellon J, Pidherney M, Mayhew E, Anand R. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res. 1993;12:347-358.
9. Radinsky R. Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer. 1995;31:1091-1095.
10. Khazaie K, Schirrmacher V, Lichtner RB. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev. 1993;12:255-274.
11. Carlin CR, Simon D, Mattison J, Knowles BB. Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines. Mol Cell Biol. 1988;8:25-34.
12. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Growth regulation of human renal carcinoma cells: role of transforming growth factor-α. Cancer Res. 1992;52:3335-3339.
13. Maurizi M, Scambia G, Benedetti Panici P, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer. 1992;52:862-866.
14. Ozawa S, Ueda M, Ando N, Abe O, Hirai M, Shimuzu N. Stimulation by EGF of the growth of EGF receptor-hyper-producing tumor cells in athymic mice. Int J Cancer. 1987:706-710.
15. Damstrup L, Rygaard K, Spang-Thomsen M, Poulsen HS. Expression of the EGFR in human small cell lung cancer cell lines. Cancer Res. 1992;52:3089-3093.
16. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci. 1989;30:829-834.
17. + cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunotber. 1994;38:399-405.
18. Ksander BR, Rubsamen P, Olsen K, Cousins S, Streilein JW. Studies of tumor-infiltrating lymphocytes from a choroidal melanoma. Invest Ophthalmol Vis Sci. 1991;32:3198-3208.
19. Albert DM, Ruzzo MA, McLaughlin MA, Robinson NL, Craft JL, Epstein J. Establishment of cell lines of uveal melanoma. Invest Ophthalmol Vis Sci. 1984;25:1284-1299.
20. Waard-Siebinga ID, Blom D-JR, Griffioen M, et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer. 1995;62:155-161.
21. Luyten GPM, Mooy CM, De Jong PTVM, Hoogeveen AT, Luider TM. A chicken embryo model to study the growth of human uveal melanoma. Res Commun. 1993;192:22-29
22. Niederkorn JY, Streilein JW, Shadduck JA. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci. 1981;20:355-363.
23. Quax PHA, van Muijen GNP, Weening-Verhoeff EJD, et al. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol. 1991; 115:191-199.
24. Van Muijen GNP, Janssen CFJ, Cornelissen IMAH, Smeets DFCM, Beck JLM, Ruiter DJ. Establishment and characterization of a new human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer. 1990;48:85-91.
25. Ma D, Niederkorn JY. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice. Invest Ophthalmol Vis Sci. 1995;36: 1067-1075.
26. Ma D, Luyten GP, Luider TM, Niederkorn JY. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci. 1995;36:435-441.
27. Donoso LA, Shields JA, Augsburger JJ, Whitman J, Arbizo V. Antigenic and cellular heterogeneity of primary uveal malignant melanomas. Arch Ophthalmol. 1986;104:106-110.
28. Nishikawa K, Rotbein J, Vijjeswarapu D, Owen-Schaub L, Rosenblum MG, Donato NJ. Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferation. Lympbokine Cytokine Res. 1994;13:37-45.
29. Gospodarowicz D. Epidermal and nerve growth factors in mammalian development. Annu Rev Physiol. 1981;43:251-263
30. Prigent S, Lemoine NR. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res. 1992; 4:1-24.
31. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGFR-like growth factor: multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992;267:6205-6212.
32. Wong ST, Winchell LF, McCune BK, et al. The TGF-α precursor expressed on the cell surface binds to the EGF-receptor on adjacent cells, leading to signal transduction. Cell. 1989;56:495-506.
33. Paget S. The distribution of secondary growths in cancer of the breast Lancet. 1889;1:571-573.